Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes

Article in Journal of Clinical Medicine (January 2024)

Better Detection of Peripheral Arterial Disease with Toe-Brachial Index Compared to Ankle-Brachial Index among Taiwanese Patients with Diabetic Kidney Disease

Article in Journal of Clinical Medicine (November 2023)

Effect of vildagliptin, a dipeptidyl peptidase-4 inhibitor, on parameters of glucose metabolism and cardio-ankle vascular index (CAVI) in individuals with type 2 diabetes

Preprint in Research Square (September 2023)